Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 803 results for "tyrosine"

Osimertinib outplays chemotherapy in EGFR T790M-positive advan...

medwireNews : The third-generation tyrosine kinase inhibitor (TKI) osimertinib significantly improves outcomes relative to platinum-based chemotherapy plus pemetrexed in advanced non-small-cell lung cancer (NSCLC) patients who have acquired the ... MedWire News, 1 day ago
Osimertinib or PlatinumPemetrexed in EGFR T790MPositive Lung Cancer New England Journal of Medicine, 4 days ago

41 images for tyrosine

Cancer Therapy Advisor, 4 days ago
Pharmaceutical Business Review, 4 days ago
MDPI, 4 days ago
International Journal of Laboratory Hematology, 3 weeks ago
DirectorsTalk, 1 month ago
Proactive Investors.co.uk, 1 month ago
Ecancer Medicalscience, 1 month ago
VideoBasedTutorials, 1 month ago
Cancer Therapy Advisor, 1 month ago
MedIndia, 1 month ago
Med India

Stopping Drug Therapy for CML: EURO-SKI Results

SAN DIEGO — Once patients with chronic myeloid leukemia (CML) are in remission from their disease, can treatment with tyrosine kinase inhibitors (TKIs) such as imatinib be discontinued? Several smaller studies have suggested it is feasible, and ...
 General Medicine eJournal4 days ago Cutting Dose, Instead of Stopping Therapy, in Patients With CML  General Medicine eJournal4 days ago New Approach Being Explored for the Treatment of Chronic Myeloid Leukemia  Med India2 months ago Overview of the Current Development Landscape in Chronic Lymphocytic Leukemia, Part 3  Oncology Pharmacist.com19 hours ago

Gilead Sciences: Nothing to See Here…Except the Need for M&A

After Gilead Sciences (GILD) provided updates on its Bruton's tyrosine kinase, or BTK, and spleen tyrosine kinase, or Syk, hematology programs American Society of Hematology, Credit Suisse analyst
 Yahoo! Finance4 days ago
[x]  

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2016

Summary 's, ' ', provides in depth analysis on Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) targeted pipeline therapeutics. The report provides comprehensive information on the Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or ...
 Global Information Inc1 day ago Brutons Tyrosine Kinase Inhibitors Overview and Comparative Analysis 2016  Before It's News3 days ago Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors -Pipeline Insights, 2016  Yahoo! Finance1 week ago The Bruton's tyrosine kinase (BTK) inhibitor acalabrutinib demonstrates potent on-target effects and efficacy in two mouse models of chronic lymphocytic leukemia  Clinical Cancer Research1 week ago
[x]  

Global N-Benzoyl-L-Tyrosine (CAS 2566-23-6) Market Report 2016 - Forecasts to 2020 - Research and Markets

Research and Markets has announced the addition of the "Global Market Report On N-Benzoyl-L-Tyrosine 2016" report to their offering. The Global Market Report on N-Benzoyl-L-Tyrosine provides comprehensive data on N-Benzoyl-L-Tyrosine global and ...
 4 Traders4 days ago ONCOLOGY DRUG REPORT : Xalkori & Crizotinib - 2011-2015 Analysis & 2016-2021 Expectations - Research and Markets  4 Traders1 day ago Oncology Drug Report: Xalkori & Crizotinib - 2011-2015 Analysis & 2016-2021 Expectations - Research and Markets  Financial Buzz1 day ago
[x]  

ACEA Biosciences Presents Efficacy and Safety Data From AC0010 Phase I/II Clinical Trial for Treatment of Advanced Non-Small Cell Lung Cancer at the WCLC 2016 Conference

Novel EGFR tyrosine kinase inhibitor AC0010 displays high efficacy, tolerability, and safety in phase I/II clinical trials. San Diego (PRWEB) December 07, 2016 ACEA Biosciences, Inc. presented today updated efficacy and safety data from its ...
 SSUChronicle.com2 days ago
[x]  

Global Cancer Tyrosine Kinase Inhibitors Market & Clinical Pipeline Outlook 2020

LONDON, Dec. 1, 2016 /PRNewswire/ -- The global increase in the prevalence of cancer and the increasing recognition of the therapeutic and commercial opportunities offered by new oncology treatments has provided a major incentive for the ...
 TickerTech.com1 week ago
[x]  

PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors

Abstract Purpose: Tyrosine kinase inhibitors are effective in gastrointestinal stromal tumors (GISTs) but often are of transient benefit as resistance commonly develops. Immunotherapy, particularly blockade of the inhibitory receptor programmed ...
 Clinical Cancer Research9 hours ago

EURO-Ski: Stopping Tyrosine Kinase Inhibitor Safe and Feasible in Chronic Myeloid Leukaemia: Presented at ASH

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 23 days for your content allowance to be renewed. Sign up for a free trial to ...
 FirstWord Pharma23 hours ago
MDPI

IJMS, Vol. 17, Pages 2073: Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients

Open Access Review Int. J. Mol. Sci. 2016 , 17 (12), 2073; doi:10.3390/ijms17122073 (registering DOI) Military Institute of Medicine Szaserów, 128 Street, 04-141 Warsaw, Poland * Author to whom correspondence should be addressed. ...
 MDPI1 day ago IJMS, Vol. 17, Pages 2038: Serum Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) Predicts the Severity of Acute Pancreatitis  MDPI4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less